The GnRH agonist goserelin is US Food and Drug Administration–approved for administration as a 3.6-mg subcutaneous implant given once every 4 weeks for the palliative treatment of premenopausal and ...

The 2.5 mg/0.5 ml dosage rounds out Ritedose's complete portfolio of albuterol treatments, as the company currently has approved applications for (2.5 mg/3 mL (0.083%), 1.25 mg/3 mL and 0.63 mg/3 ...

The 2.5 mg/0.5 ml dosage rounds out Ritedose's complete portfolio of albuterol treatments, as the company currently has approved applications for (2.5 mg/3 ml (0.083%), 1.25 mg/3 ml and 0.63 mg/3 ...

The 2.5 mg/0.5 ml dosage rounds out Ritedose's complete portfolio of albuterol treatments, as the company currently has approved applications for (2.5 mg/3 mL (0.083%), 1.25 mg/3 mL and 0.63 mg/3 mL) ...

The cost of levalbuterol in health care facilities has been reported to be 5 to 25 times higher than that of albuterol (in our center, levalbuterol costs $1.85 per 1.25-mg/2.5-mL dose, versus $0. ...

Direct precipitation of salbutamol sulfate (SS) by antisolvent crystallization in the presence of surfactants and polymeric additives was investigated to obtain micrometer-sized SS for use in inhaled ...

Results: Our results reveal that Mg-sulfate can obscure the carbonate signature, especially the 2.3 µm band. Discussion: These findings suggest that Mg-sulfate deposits may mask carbonates from ...